Omid Farokhzad
Vermogen: 10 M $ op 31-07-2026
Vermogen: 10 M $ op 31-07-2026
Oprichter van 5 verschillende bedrijven, waaronder: Seer, Inc. (Californië), Selecta Biosciences, Inc. en DNIB Unwind, Inc. Omid C. Farokhzad is ondernemer en is Chairman & Chief Executive Officer voor Seer, Inc. (Californië) (dat hij in 2017 oprichtte). Hij zit ook in de raad van bestuur van Placon Therapeutics, Inc. In zijn vorige carrière was hij voorzitter voor Selecta Biosciences, Inc. (hij richtte het bedrijf op in 2007), Associate Professor aan de Harvard Medical School, Directeur bij DNIB Unwind, Inc. en Directeur bij Tarveda Therapeutics, Inc. Dr. Farokhzad behaalde een doctoraat en een graduaatsdiploma aan de Boston University School of Medicine en een MBA aan het Massachusetts Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SEER, INC. CLASS A 7,96% | 11-05-2026 | 4.403.724 ( 7,96% ) | 10 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SEER, INC. | Algemeen Directeur | 01-03-2018 |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Directeur/Bestuurslid | - |
Xlink Therapeutics, Inc. | Oprichter | - |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Oprichter | 01-01-2020 |
Xira Connect, Inc. | Directeur/Bestuurslid | 01-08-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Directeur/Bestuurslid | 25-11-2024 |
| DYNC SPL | Voorzitter | 01-06-2022 |
| CARTESIAN THERAPEUTICS, INC. | Oprichter | 19-11-2019 |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Oprichter | 01-01-2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 15 |
|---|---|
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Semaphore, Inc.
Semaphore, Inc. Packaged SoftwareTechnology Services Develops and distributes advanced financial and project management software | Technology Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Health Technology |
Seer, Inc. (California)
Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
Dynamics Special Purpose Corp.
Dynamics Special Purpose Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Xlink Therapeutics, Inc. | |
Xira Connect, Inc. | |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau